Upregulation of miR-196b-5p attenuates BCG uptake via targeting SOCS3 and activating STAT3 in macrophages from patients with long-term cigarette smoking-related active pulmonary tuberculosis

被引:22
作者
Yuan, Yaoqin [2 ]
Lin, Dongzi [1 ,2 ]
Feng, Long [1 ]
Huang, Mingyuan [1 ]
Yan, Huimin [1 ,3 ]
Li, Yumei [2 ]
Chen, Yinwen [2 ]
Lin, Bihua [1 ]
Ma, Yan [1 ]
Ye, Ziyu [1 ]
Mei, Yuezhi [2 ]
Yu, Xiaolin [2 ]
Zhou, Keyuan [1 ]
Zhang, Qunzhou [4 ]
Chen, Tao [3 ]
Zeng, Jincheng [1 ,4 ]
机构
[1] Guangdong Med Univ, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan Key Lab Med Bioact Mol Dev & Translat Re, Dongguan 523808, Guangdong, Peoples R China
[2] Dongguan Sixth Peoples Hosp, Dongguan 523008, Guangdong, Peoples R China
[3] Ctr TB Control Guangdong Prov, Prov TB Reference Lab Guangdong, Guangzhou 510630, Guangdong, Peoples R China
[4] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg & Pharmacol, Philadelphia, PA 19104 USA
来源
JOURNAL OF TRANSLATIONAL MEDICINE | 2018年 / 16卷
基金
中国国家自然科学基金;
关键词
MiR-196b-5p; Cigarette smoking; Macrophages; STAT3 signaling pathway; Tuberculosis; TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; TNF-ALPHA; T-CELLS; INFECTION; EXPRESSION; MONOCYTES; RESPONSES; INFLAMMATION;
D O I
10.1186/s12967-018-1654-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundCigarette smoking (CS) triggers an intense and harmful inflammatory response in lungs mediated by alveolar and blood macrophages, monocytes, and neutrophils and is closely associated with prevalence of tuberculosis (TB). The risk of death in patients with long-term cigarette smoking-related pulmonary tuberculosis (LCS-PTB) is approximately 4.5 times higher than those with nonsmoking pulmonary tuberculosis (N-PTB). However, the mechanisms underlying the harmful inflammatory responses in the setting of LCS-PTB have not been well documented.Methods28 cases LCS-PTB patients, 22 cases N-PTB patients and 20 cases healthy volunteers were enrolled in this study. Monocytes were isolated from peripheral blood mononuclear cells. Differentiated human MDM and U937 cell were prepared with M-CSF and PMA stimulation, respectively. The miR-196b-5p, STAT1, STAT3, STAT4, STAT5A, STAT5B, STAT6, SOCS1 and SOCS3 mRNA expression were detected by qRT-PCR. Western blot was performed according to SOCS1, SOCS3, and pSTAT3 expression. The mycobacterial uptake by MDMs from different groups of patients after Bacillus Calmette-Guerin (BCG) infection and agomir-196b-5p or antagomir-196b-5p transfection were used by flow cytometry analysis. Human IL-6, IL-10 and TNF- levels on the plasma and cell culture supernatant samples were measured using ELISA. For dual-luciferase reporter assay, the SOCS3 3-UTR segments, containing the binding elements of miR-196b-5p or its mutant versions were synthesized as sense and antisense linkers.ResultsIn this study, we found that IL-6, TNF- production, SOCS3 mRNA expression were downregulated, while miR-196b-5p and STAT3 mRNA expression were upregulated in monocytes from LCS-PTB patients as compared to N-PTB patients. Meanwhile, we demonstrated that miR-196b-5p could target SOCS3 and activate STAT3 signaling pathway, which may possibly contribute to attenuation of BCG uptake and decrease in IL-6 and TNF- production in macrophages.ConclusionsOur findings revealed that CS exposure regulates inflammatory responses in monocyte/macrophages from LCS-PTB patients via upregulating miR-196b-5p, and further understanding of the specific role of miR-196b-5p in inflammatory responses mightfacilitate elucidating the pathogenesis of LCS-PTB, thus leading to the development of new therapeutic strategies for PTB patients with long-term cigarette smoking.
引用
收藏
页数:13
相关论文
共 55 条
  • [1] Perturbed microRNA expression by Mycobacterium tuberculosis Promotes Macrophage Polarization leading to Pro-survival Foam cell
    Ahluwalia, Pankaj Kumar
    Pandey, Rajan Kumar
    Sehajpal, Prabodh Kumar
    Prajapati, Vijay Kumar
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994
  • [3] Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity
    Almeida, Alexandre S.
    Lago, Patricia M.
    Boechat, Neio
    Huard, Richard C.
    Lazzarini, Luiz C. O.
    Santos, Adalberto R.
    Nociari, Marcelo
    Zhu, Hongxia
    Perez-Sweeney, Beatriz M.
    Bang, Heejung
    Ni, Quanhong
    Huang, Jie
    Gibson, Andrea L.
    Flores, Vera C.
    Pecanha, Lorena R.
    Kritski, Afranio L.
    Lapa e Silva, Jose R.
    Ho, John L.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (01) : 718 - 731
  • [4] Aryanpur M, 2016, IRAN J ALLERGY ASTHM, V15, P174
  • [5] Risk of tuberculosis from exposure to tobacco smoke - A systematic review and meta-analysis
    Bates, Michael N.
    Khalakdina, Asheena
    Pai, Madhukar
    Chang, Lisa
    Lessa, Fernanda
    Smith, Kirk R.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (04) : 335 - 342
  • [6] Tumour necrosis factor-alpha and nitric oxide response in different categories of tuberculosis patients
    Chakraborty, U.
    Goswami, A.
    Saha, S.
    Mukherjee, T.
    Dey, S. K.
    Majumdar, S.
    Pal, N. K.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (04) : 505 - 510
  • [7] High IL-6 and low IL-15 levels mark the presence of TB infection: A preliminary study
    Chandrashekara, S.
    Anupama, K. R.
    Sambarey, Awanti
    Chandra, Nagasuma
    [J]. CYTOKINE, 2016, 81 : 57 - 62
  • [8] Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis
    Chuang, Hsiao-Chi
    Su, Chien-Ling
    Liu, Hui-Chiao
    Feng, Po-Hao
    Lee, Kang-Yun
    Chuang, Kai-Jen
    Lee, Chun-Nin
    Bien, Mauo-Ying
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1539 - 1544
  • [9] Time course of cigarette smoke-induced pulmonary inflammation in mice
    D'hulst, AI
    Vermaelen, KY
    Brusselle, GG
    Joos, GF
    Pauwels, RA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (02) : 204 - 213
  • [10] MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia
    Diaz-Beya, M.
    Brunet, S.
    Nomdedeu, J.
    Tejero, R.
    Diaz, T.
    Pratcorona, M.
    Tormo, M.
    Ribera, J. M.
    Escoda, L.
    Duarte, R.
    Gallardo, D.
    Heras, I.
    de Llano, M. P. Queipo
    Bargay, J.
    Monzo, M.
    Sierra, J.
    Navarro, A.
    Esteve, J.
    [J]. LEUKEMIA, 2014, 28 (04) : 804 - 812